Headline Details

Hitting cancer early: AstraZeneca's bid to outmaneuver rivals

Published on: Fri, 06 Jul 2018 7:28:16 UTC
News Agency: Reuters
Description:
AstraZeneca suffered its biggest daily share price drop a year ago after a key cancer drug trial failed amid feverish speculation the chief executive might quit.

Click here for FULL Story on Reuters

Also happening now

HeadlineNews Agency
New Hungary law bans rough sleepers, rights groups complain Reuters
Syria reopens key crossings with Jordan and Israel-occupied Golan BBC
German police suspect hostage has been taken in Cologne Reuters
Spain calls for urgent investigation into disappearance of Saudi journalist Reuters
Jamal Khashoggi: Turkey 'to search Saudi consulate' in Istanbul BBC